Trimel Pharmaceuticals Corporation
TSX : TRL

Trimel Pharmaceuticals Corporation

November 06, 2014 10:55 ET

CORRECTION FROM SOURCE: Trimel Reports Third Quarter 2014 Financial Results

- EBITDA(1) of ($3.4) million, Adjusted EBITDA(1) of $0.4 million

TORONTO, ONTARIO--(Marketwired - Nov. 6, 2014) - Trimel Pharmaceuticals Corporation (TSX:TRL) -

A correction from source is being issued with respect to the release issued today at 8:00 am ET. The third bullet point in the subtitle has been amended from, "EBITDA(1) of ($3.4) million, Adjusted EBITDA(1) of $0.3 million" to "EBITDA(1) of ($3.4) million, Adjusted EBITDA(1) of $0.4 million".

The complete and corrected third quarter report can be viewed at the following link: http://www.marketwired.com/press-release/trimel-reports-third-quarter-2014-financial-results-tsx-trl-1965172.htm.

Contact Information